SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-16
👔
AIM ImmunoTech Inc.
@AIM_InsiderForm 4 Filing: Equels Thomas K Buys $5K of $AIM
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
AIM ImmunoTech Inc.
Ticker: $AIM
Transaction Value
$5K
Price/Share: $0.22
transaction date
2026-09-15
Shares: 22,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Equels Thomas K, holds the title of CEO & President at AIM ImmunoTech Inc..
On 2026-09-15, the insider transacted 22,000 shares.The shares were transacted at a weighted average price of $0.22 per share, resulting in a total market-relevant value of $5K.
Executive Summary Summary
Equels Thomas K (CEO & President) bought $5K of $AIM
Post-Transaction Position: 91,822 shares
SEC Accession No: 0001493152-26-042848 (CIK: 1450324)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.